Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. (INO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INO · as of Jun 9, 2026
Key Statistics
Explore Inovio Pharmaceuticals, Inc. Data
ino stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 17 · Buy rate: 52.9%
The INO analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $2.50, representing +129.36% upside from the current price of $1.09.
Competitors & Peers
ino competitorsINO
ABOS
ACTU
AGEN
ALEC
FATEStock Performance
Full HistoryAbout Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associat…
what is inovio pharmaceuticals, inc. · ino stock overview · inovio pharmaceuticals, inc. company profile · who is inovio pharmaceuticals, inc. ceo · ino NASDAQ · inovio pharmaceuticals, inc. headquarters · inovio pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Inovio Pharmaceuticals, Inc. (INO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 8, 1998. As of the latest trading session, INO stock price is $1.09, with a market capitalization of $58.4M. The stock has returned -50.90% over the past 12 months and -37.36% year-to-date.
According to 17 Wall Street analysts, the consensus rating for Inovio Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $2.50. In fiscal year 2025, Inovio Pharmaceuticals, Inc. reported revenue of $65343.00 and net income of -$84.9M. For detailed data — including Inovio Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Inovio Pharmaceuticals, Inc. (INO) stock price is $1.09. The stock is traded on NASDAQ under the ticker symbol INO. The 52-week range is $1.03 – $2.98.